Replies to post #94393 on Regen BioPharma Inc (RGBP)

[29YEARINVESTOR]

Eli Lilly and RGBP have a history and Eli Lilly was waiting on the human patent RGBNP JUST GOT:

Eli Lilly (LLY) & RGBP Partner in Small Molecules Immuno-Oncology - Autoimmunization NR2F6 Program. They Currently Await New Patents, Etc. News of Approval.
The Intended Result is Oral Drugs-Therapies-Treatment for Cancers & Auto Immune Diseases.
Specializing in Cutting Edge Technology.

https://www.otcmarkets.com/filing/html?id=15246005&guid=0UBwkePH2yzmJth

https://www.otcmarkets.com/filing/conv_pdf?id=15189224&guid=0UBwkePH2yzmJth

Check out the new patents that we have all been waiting for along with what Eli Lilly was waiting for from previous studies together!
The sky is the limit IMO!

$RGBP $RGBPP connection to $LLY (Eli Lilly one of the TOP pharmaceutical co in the world)
Jean-Pierre Millon was executive 23 years @ LLY and would not have been associated with Regen unless he knew the significance of NR2F6 imo
Connected to $CVS n GPP a $2.2 TRILLION hedge fund! pic.twitter.com/o0C7Hz8k3R

— ⚡️420⚡️ (@WZ_420) August 29, 2021

https://www.biospace.com/article/releases/regen-biopharma-inc-announces-former-eli-lilly-executive-and-current-cvs-board-member-will-lead-newly-formed-business-advisory-board-bab-/

https://www.prnewswire.com/news-releases/regen-biopharma-inc-enters-into-open-innovation-drug-discovery-program-agreement-with-eli-lilly-and-company-585014641.html

https://www.hvst.com/posts/ongoing-agreement-with-eli-lilly-leads-to-discovery-of-several-new-small-molecule-drugs-wm4T1ZDp